Generation Bio Co Stock Analysis

Generation Stock Analysis Notes

About 14.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.4. Some equities with similar Price to Book (P/B) outperform the market in the long run. Generation Bio recorded a loss per share of 1.08. The entity had not issued any dividends in recent years. Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Generation Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 150 people. To learn more about Generation Bio Co call Cameron MD at 617 655 7500 or check out https://generationbio.com.

Generation Bio Investment Alerts

Generation Bio Upcoming and Recent Events

Generation Largest EPS Surprises

View All Earnings Estimates

Generation Stock Institutional Investors

Note, although Generation Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Generation Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 34.95 M.

Generation Profitablity

The company has Profit Margin (PM) of (2.93) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.77) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.77.

Management Efficiency

Generation Bio has return on total asset (ROA) of (0.1897) % which means that it has lost $0.1897 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.7006) %, meaning that it created substantial loss on money invested by shareholders. Generation Bio's management efficiency ratios could be used to measure how well Generation Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of July 2025, Return On Tangible Assets is likely to drop to -0.6. In addition to that, Return On Capital Employed is likely to drop to -0.76. At this time, Generation Bio's Total Assets are very stable compared to the past year. As of the 19th of July 2025, Non Current Assets Total is likely to grow to about 60.4 M, while Net Tangible Assets are likely to drop about 174.3 M.

Technical Drivers

As of the 19th of July, Generation Bio retains the Risk Adjusted Performance of 0.0619, market risk adjusted performance of 0.3976, and Downside Deviation of 7.25. Generation Bio technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Generation Bio Price Movement Analysis

Generation Bio Insider Trading Activities

Generation Bio Outstanding Bonds

Generation Bio Predictive Daily Indicators

Generation Bio Forecast Models

Generation Bio's time-series forecasting models are one of many Generation Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Generation Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Generation Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Generation shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Generation Bio. By using and applying Generation Stock analysis, traders can create a robust methodology for identifying Generation entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Generation analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Generation analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Generation Bio Co stock analysis indicators help investors evaluate how Generation Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Generation Bio shares will generate the highest return on investment. By understating and applying Generation Bio stock analysis, traders can identify Generation Bio position entry and exit signals to maximize returns.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Generation Bio Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Generation Bio. If investors know Generation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Generation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Generation Bio is measured differently than its book value, which is the value of Generation that is recorded on the company's balance sheet. Investors also form their own opinion of Generation Bio's value that differs from its market value or its book value, called intrinsic value, which is Generation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Generation Bio's market value can be influenced by many factors that don't directly affect Generation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Generation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Generation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Generation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.